Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis.
about
Is there a link between inflammation and fatigue in multiple sclerosis?Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy.A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patientsDoes Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the LiteratureEssential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future PerspectiveRegulatory B and T lymphocytes in multiple sclerosis: friends or foes?
P2860
Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Emerging Understanding of the ...... eatment of Multiple Sclerosis.
@en
Emerging Understanding of the ...... eatment of Multiple Sclerosis.
@nl
type
label
Emerging Understanding of the ...... eatment of Multiple Sclerosis.
@en
Emerging Understanding of the ...... eatment of Multiple Sclerosis.
@nl
prefLabel
Emerging Understanding of the ...... eatment of Multiple Sclerosis.
@en
Emerging Understanding of the ...... eatment of Multiple Sclerosis.
@nl
P2093
P2860
P356
P1476
Emerging Understanding of the ...... eatment of Multiple Sclerosis.
@en
P2093
Andrew Plave
Elizabeth A Mills
Magdalena A Ogrodnik
Yang Mao-Draayer
P2860
P356
10.3389/FNEUR.2018.00005
P577
2018-01-23T00:00:00Z